An interventional study of SAATH Intervention in Physical Inactivity and South Asian, sponsored by Northwestern University. Completed at 1 site in United States. Open to female participants aged 11 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-22.
Sponsored by Northwestern University · Not applicable, Interventional, and Prevention
South Asian immigrant women and girls are at increased risk for insufficient physical activity and are not being reached by current approaches to physical activity promotion. This randomized control trial study will test the effectiveness and implementation of a multi component physical activity intervention directed at the environment, family, interpersonal and individual levels to promote physical activity among South Asian immigrant mothers and daughters.
368 studies on the registry are indexed under Sedentary Behavior; 165 are open to participants now.
This study's enrollment of 252 is above the median of 70 across 314 interventional studies indexed under Sedentary Behavior.
Browse Sedentary Behavior studies →Northwestern University is the lead sponsor of 1,420 studies on the registry; 199 are open to participants now.
Of its 103 completed or terminated interventional studies of FDA-regulated products, 75 (73%) have results posted.
Counted across the registry records on this site, refreshed daily.
The sample of this study is South Asian mothers and their daughters. The inclusion criteria for the mother include:
Exclusion Criteria:
The intervention group will receive a 18-week in-person program. The program includes the following components: multi family group counseling, group exercise classes, mother group discussion, daughter group discussion and Fitbit.
Behavioral: SAATH Intervention
The group group will receive print materials about physical activity.
SAATH intervention is a physical activity intervention for South Asian mothers and daughters with group exercise classes and discussion groups.
Averaged daily minutes spent in moderate- and vigorous-intensity physical activity measured by ActiGraph accelerometers
Moderate- and vigorous-intensity physical activity will be identified based on the accelerometer count cut-point for moderate intensity and daily minutes spent in moderate- and vigorous-intensity physical activity estimated for seven days will be averaged
Time frame: The outcome will be assessed before the intervention (week 0) and after the intervention (week 18)
Averaged daily minutes spent in walking or running behavior measured by ActiGraph accelerometers
Walking and running behavior will be recognized using a machine learning activity recognition algorithm and daily minutes spent in walking or running behavior estimated for seven days will be averaged
Time frame: The outcome will be assessed before the intervention (week 0) and after the intervention (week 18)
Averaged daily hours spent in sedentary behaviors measured by ActiGraph accelerometers
Sedentary behaviors will be identified based on the accelerometer count cut-point for sedentary behaviors and daily minutes spent in sedentary behaviors estimated for seven days will be averaged
Time frame: The outcome will be assessed before the intervention (week 0) and after the intervention (week 18)
Systolic and diastolic blood pressure (mmHg) measured by a sphygmomanometer
Blood pressure will be measured three times while sitting down and relaxing on a chair and the last two measures will be averaged
Time frame: The outcome will be assessed before the intervention (week 0) and after the intervention (week 18)
Self-efficacy score measured by the Exercise Confidence Survey
The self-efficacy score will be calculated by averaging the responses (scored 1 to 5 point for the responses of strongly disagree to strongly agree) from each question item
Time frame: The outcome will be assessed before the intervention (week 0) and after the intervention (week 18)
Self-efficacy score measured by Dishman's Barriers to Self-Efficacy questionnaire
The self-efficacy score will be calculated by averaging the responses (scored 1 to 5 point; higher scores mean higher self-efficacy \[a better outcome\])
Time frame: The outcome will be assessed before the intervention (week 0) and after the intervention (week 18)
Ran from Aug 2020 to primary completion in Mar 2024, 43 months.
Of 243 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 43. This study's 43 months is above that.
Counting every sponsor, half of 246 studies reached it within 22 months; a quarter within 9 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.